As pharmacy benefit managers face ongoing criticism over their role in rising prescription drug prices, Express Scripts Holding Co. is touting its decisions to increase the number of drugs excluded from its 2018 national preferred formulary to 159 as a cost saving move.
The change will produce $2.5bn in estimated savings for its payer clients, up from $1.8bn in 2017, the PBM estimates.